| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
23andMe Holding Co. Class A Common Stock (NASDAQ: ME)
ME Technical Analysis
5
| As on 28th Mar 2025 ME STOCK Price closed @ 0.61 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.96 & Strong Sell for SHORT-TERM with Stoploss of 3.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MESTOCK Price
| Open | 0.75 | Change | Price | % |
| High | 1.10 | 1 Day | -0.16 | -20.78 |
| Low | 0.60 | 1 Week | -1.23 | -66.85 |
| Close | 0.61 | 1 Month | -1.86 | -75.30 |
| Volume | 29241793 | 1 Year | -2.94 | -82.82 |
| 52 Week High 4.05 | 52 Week Low 0.53 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 177.82 | -2.59% |
| OPEN | 7.74 | 0.65% |
| LMDX | 0.02 | 0.00% |
| ONDS | 8.44 | -3.21% |
| AKTS | 0.04 | 0.00% |
| GOOGL | 323.44 | 1.53% |
| PLUG | 1.95 | -0.51% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ME Daily Charts |
ME Intraday Charts |
Whats New @ Bazaartrend |
ME Free Analysis |
|
|
ME Important Levels Intraday
| RESISTANCE | 1.57 |
| RESISTANCE | 1.26 |
| RESISTANCE | 1.07 |
| RESISTANCE | 0.88 |
| SUPPORT | 0.34 |
| SUPPORT | 0.15 |
| SUPPORT | -0.04 |
| SUPPORT | -0.35 |
ME Forecast November 2025
| 4th UP Forecast | 4 |
| 3rd UP Forecast | 2.91 |
| 2nd UP Forecast | 2.24 |
| 1st UP Forecast | 1.57 |
| 1st DOWN Forecast | -0.35 |
| 2nd DOWN Forecast | -1.02 |
| 3rd DOWN Forecast | -1.69 |
| 4th DOWN Forecast | -2.78 |
ME Weekly Forecast
| 4th UP Forecast | 2.34 |
| 3rd UP Forecast | 1.79 |
| 2nd UP Forecast | 1.44 |
| 1st UP Forecast | 1.10 |
| 1st DOWN Forecast | 0.12 |
| 2nd DOWN Forecast | -0.22 |
| 3rd DOWN Forecast | -0.57 |
| 4th DOWN Forecast | -1.12 |
ME Forecast2025
| 4th UP Forecast | 7.64 |
| 3rd UP Forecast | 5.39 |
| 2nd UP Forecast | 3.99 |
| 1st UP Forecast | 2.6 |
| 1st DOWN Forecast | -1.38 |
| 2nd DOWN Forecast | -2.77 |
| 3rd DOWN Forecast | -4.17 |
| 4th DOWN Forecast | -6.42 |
23andMe Holding Co. Class A Common Stock ( NASDAQ USA Symbol : ME )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ME Business Profile
23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize promising drugs. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. The company was founded in 2006 and is headquartered in Sunnyvale, California. Address: 223 North Mathilda Avenue, Sunnyvale, CA, United States, 94086
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service